<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>(Allergy Asthma Clin Immunol[TA])</title><link>http://www.unboundmedicine.com/medline//journal/Allergy_Asthma_Clin_Immunol</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Reviewer acknowledgement 2012.</title><link>http://www.unboundmedicine.com/medline/citation/23659583/Reviewer_acknowledgement_2012_</link><description><div class="result"><ul><li class="author">Warrington R </li><li class="title"><a href="./citation/23659583/Reviewer_acknowledgement_2012_">Reviewer acknowledgement 2012.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013; 9(1):3.</li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">CONTRIBUTING REVIEWERS: The editors of Allergy, Asthma &amp; Clinical Immunology would like to thank all of our reviewers who have contributed to the journal in Volume 8 (2012).</div></div></div></description></item><item><title>Conducting retrospective impact analysis to inform a medical research charity's funding strategies: the case of Asthma UK.</title><link>http://www.unboundmedicine.com/medline/citation/23651523/Conducting_retrospective_impact_analysis_to_inform_a_medical_research_charity's_funding_strategies:_the_case_of_Asthma_UK_</link><description><div class="result"><ul><li class="author">Hanney SR, Watt A, Jones TH, et al. </li><li class="title"><a href="./citation/23651523/Conducting_retrospective_impact_analysis_to_inform_a_medical_research_charity's_funding_strategies:_the_case_of_Asthma_UK_">Conducting retrospective impact analysis to inform a medical research charity's funding strategies: the case of Asthma UK.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013; 9(1):17.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23651523/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/17">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Debate is intensifying about how to assess the full range of impacts from medical research. Complexity increases when assessing the diverse funding streams of funders such as Asthma UK, a charitable patient organisation supporting medical research to benefit people with asthma. This paper aims to describe the various impacts identified from a range of Asthma UK research, and explore how Asthma UK utilised the characteristics of successful funding approaches to inform future research strategies.We adapted the Payback Framework, using it both in a survey and to help structure interviews, documentary analysis, and case studies. We sent surveys to 153 lead researchers of projects, plus 10 past research fellows, and also conducted 14 detailed case studies. These covered nine projects and two fellowships, in addition to the innovative case studies on the professorial chairs (funded since 1988) and the MRC-Asthma UK Centre in Allergic Mechanisms of Asthma (the 'Centre') which together facilitated a comprehensive analysis of the whole funding portfolio. We organised each case study to capture whatever academic and wider societal impacts (or payback) might have arisen given the diverse timescales, size of funding involved, and extent to which Asthma UK funding contributed to the impacts.Projects recorded an average of four peer-reviewed journal articles. Together the chairs reported over 500 papers. All streams of funding attracted follow-on funding. Each of the various categories of societal impacts arose from only a minority of individual projects and fellowships. Some of the research portfolio is influencing asthma-related clinical guidelines, and some contributing to product development. The latter includes potentially major breakthroughs in asthma therapies (in immunotherapy, and new inhaled drugs) trialled by university spin-out companies. Such research-informed guidelines and medicines can, in turn, contribute to health improvements. The role of the chairs and the pioneering collaborative Centre is shown as being particularly important.We systematically demonstrate that all types of Asthma UK's research funding assessed are making impacts at different levels, but the main societal impacts from projects and fellowships come from a minority of those funded. Asthma UK used the study's findings, especially in relation to the Centre, to inform research funding strategies to promote the achievement of impact.</div></div></div></description></item><item><title>A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis.</title><link>http://www.unboundmedicine.com/medline/citation/23635091/A_four_way_double_blind_randomized_placebo_controlled_study_to_determine_the_efficacy_and_speed_of_azelastine_nasal_spray_versus_loratadine_and_cetirizine_in_adult_subjects_with_allergen_induced_seasonal_allergic_rhinitis_</link><description><div class="result"><ul><li class="author">Ellis AK, Zhu Y, Steacy LM, et al. </li><li class="title"><a href="./citation/23635091/A_four_way_double_blind_randomized_placebo_controlled_study_to_determine_the_efficacy_and_speed_of_azelastine_nasal_spray_versus_loratadine_and_cetirizine_in_adult_subjects_with_allergen_induced_seasonal_allergic_rhinitis_">A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013 May 1; 9(1):16.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23635091/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/16">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract"><h3>BACKGROUND:</h3> Azelastine has been shown to be effective against seasonal allergic rhinitis (SAR). The Environmental Exposure Unit (EEU) is a validated model of experimental SAR. The objective of this double-blind, four-way crossover study was to evaluate the onset of action of azelastine nasal spray, versus the oral antihistamines loratadine 10 mg and cetirizine 10 mg in the relief of the symptoms of SAR. <h3>METHODS:</h3> 70 participants, aged 18-65, were randomized to receive azelastine nasal spray, cetirizine, loratadine, or placebo after controlled ragweed pollen exposure in the EEU. Symptoms were evaluated using the total nasal symptom score (TNSS). The primary efficacy parameter was the onset of action as measured by the change from baseline in TNSS. <h3>RESULTS:</h3> Azelastine displayed a statistically significant improvement in TNSS compared with placebo at all time points from 15 minutes through 6 hours post dose. Azelastine, cetirizine, and loratadine reduced TNSS compared to placebo with an onset of action of 15 (p &lt; 0.001), 60 (p = 0.015), and 75 (p = 0.034) minutes, respectively. The overall assessment of efficacy was rated as good or very good by 46% of the participants for azelastine, 51% of the participants for cetirizine, and 30% of the participants for loratadine compared to 18% of the participants for placebo. <h3>CONCLUSIONS:</h3> Azelastine's onset of action for symptom relief was faster than that of cetirizine and loratadine. The overall participant satisfaction in treatment with azelastine is comparable to cetirizine and statistically superior to loratadine. These results suggest that azelastine may be preferential to oral antihistamines for the rapid relief of SAR symptoms.</div></div></div></description></item><item><title>Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity.</title><link>http://www.unboundmedicine.com/medline/citation/23607879/Infant_gut_microbiota_and_the_hygiene_hypothesis_of_allergic_disease:_impact_of_household_pets_and_siblings_on_microbiota_composition_and_diversity_</link><description><div class="result"><ul><li class="author">Azad MB, Konya T, Maughan H, et al. </li><li class="title"><a href="./citation/23607879/Infant_gut_microbiota_and_the_hygiene_hypothesis_of_allergic_disease:_impact_of_household_pets_and_siblings_on_microbiota_composition_and_diversity_">Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013 Apr 22; 9(1):15.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23607879/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/15">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract"><h3>BACKGROUND:</h3> Multiple studies have demonstrated that early-life exposure to pets or siblings affords protection against allergic disease; these associations are commonly attributed to the "hygiene hypothesis". Recently, low diversity of the infant gut microbiota has also been linked to allergic disease. In this study, we characterize the infant gut microbiota in relation to pets and siblings. <h3>METHODS:</h3> The study population comprised a small sub-sample of 24 healthy, full term infants from the Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort. Mothers reported on household pets and siblings. Fecal samples were collected at 4 months of age, and microbiota composition was characterized by high-throughput signature gene sequencing. <h3>RESULTS:</h3> Microbiota richness and diversity tended to be increased in infants living with pets, whereas these measures were decreased in infants with older siblings. Infants living with pets exhibited under-representation of Bifidobacteriaceae and over-representation of Peptostreptococcaceae; infants with older siblings exhibited under-representation of Peptostreptococcaceae. <h3>CONCLUSIONS:</h3> This study provides new evidence that exposure to pets and siblings may influence the early development of the gut microbiota, with potential implications for allergic disease. These two traditionally protective "hygiene hypothesis" factors appear to differentially impact gut microbiota composition and diversity, calling into question the clinical significance of these measures. Further research is required to confirm and expand these findings.</div></div></div></description></item><item><title>Confounding with familial determinants affects the association between mode of delivery and childhood asthma medication -- a national cohort study.</title><link>http://www.unboundmedicine.com/medline/citation/23590822/Confounding_with_familial_determinants_affects_the_association_between_mode_of_delivery_and_childhood_asthma_medication____a_national_cohort_study_</link><description><div class="result"><ul><li class="author">Bråbäck L, Ekéus C, Lowe AJ, et al. </li><li class="title"><a href="./citation/23590822/Confounding_with_familial_determinants_affects_the_association_between_mode_of_delivery_and_childhood_asthma_medication____a_national_cohort_study_">Confounding with familial determinants affects the association between mode of delivery and childhood asthma medication -- a national cohort study.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013 Apr 16; 9(1):14.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23590822/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/14">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract"><h3>BACKGROUND:</h3> Mode of delivery may affect the risk of asthma but the findings have not been consistent and factors shared by siblings may confound the associations in previous studies. <h3>METHODS:</h3> The association between mode of delivery and dispensed inhaled corticosteroid (ICS) (a marker of asthma) was examined in a register based national cohort (n=199 837). A cohort analysis of all first born children aged 2-5 and 6-9 years was performed. An age-matched sibling-pair analysis was also performed to account for shared genetic and environmental risk factors. <h3>RESULTS:</h3> Analyses of first-borns demonstrated that elective caesarean section was associated with an increased risk of dispensed ICS in both 2-5 (adjusted odds ratio (aOR)=1.19, 95% confidence interval (CI) 1.09-1.29) and 6-9 (aOR=1.21, 1.09-1.34) age groups. In the sibling-pair analysis, the increased risk associated with elective caesarean section was confirmed in 2-5 year olds (aOR=1.22, 1.05-1.43) but not in 6-9 year olds (aOR=1.06, 0.78-1.44). Emergency caesarean section and vacuum extraction had some association with dispensed ICS in the analyses of first-borns but these associations were not confirmed in the sibling-pair analyses. <h3>CONCLUSIONS:</h3> Confounding by familial factors affects the association between mode of delivery and dispensed ICS. Despite this confounding, there was some evidence that elective caesarean section contributed to a modestly increased risk of dispensed ICS but only up to five years of age.</div></div></div></description></item><item><title>The development of TH2 responses from infancy to 4 years of age and atopic sensitization in areas endemic for helminth infections.</title><link>http://www.unboundmedicine.com/medline/citation/23566643/The_development_of_TH2_responses_from_infancy_to_4_years_of_age_and_atopic_sensitization_in_areas_endemic_for_helminth_infections_</link><description><div class="result"><ul><li class="author">Djuardi Y, Supali T, Wibowo H, et al. </li><li class="title"><a href="./citation/23566643/The_development_of_TH2_responses_from_infancy_to_4_years_of_age_and_atopic_sensitization_in_areas_endemic_for_helminth_infections_">The development of TH2 responses from infancy to 4 years of age and atopic sensitization in areas endemic for helminth infections.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013 Apr 8; 9(1):13.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23566643/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/13">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract"><h3>BACKGROUND:</h3> Helminth infections and allergies are associated with TH2 responses. Whereas the development of TH2 responses and allergic disorders in pediatric populations has been examined in affluent countries, no or little data exist from low income regions of the world.The aim of this study is to examine factors influencing the development of TH2 responses of children born in areas endemic for helminth infections and to relate these factors to atopic sensitization at 4 years of age. <h3>METHODS:</h3> Data were collected from pregnant mothers on helminth infections, education and socioeconomic status (SES). Total IgE, IL-5 in response to mitogen, and helminth antigens were measured in children at 2, 5, 12, 24 and 48 months of age. Skin prick testing (SPT) and allergen-specific IgE were determined at 4 years of age. <h3>RESULTS:</h3> Strong TH2 responses were seen at 5 months of age and increased with time. Although maternal filarial infection was associated with helminth-antigen specific TH2 responses, it was low maternal education or SES but not helminth infection, which was associated with the development of high total IgE and PHA-induced IL-5. At 4 years of age when allergen reactivity was assessed by SPT, the high general TH2 responses did not translate into higher SPT. The risk factor for SPT reactivity was low maternal education which decreased the risk of SPT positivity to allergens (adjusted OR, 0.32; 95% CI, 0.12 -- 0.87) independently of maternal filarial infection which tended to reduce the child's risk for being SPT positive (adjusted OR, 0.35; 95% CI, 0.07 -- 1.70). <h3>CONCLUSIONS:</h3> In areas endemic for helminths, potent TH2 responses were seen early in life, but did not translate to a higher SPT reactivity to allergens. Therefore, in many parts of the world TH2 responses in general and IgE in particular cannot be used for diagnosis of allergic diseases.</div></div></div></description></item><item><title>Drug provocation tests: up-date and novel approaches.</title><link>http://www.unboundmedicine.com/medline/citation/23551800/Drug_provocation_tests:_up_date_and_novel_approaches_</link><description><div class="result"><ul><li class="author">Chiriac AM, Demoly P </li><li class="title"><a href="./citation/23551800/Drug_provocation_tests:_up_date_and_novel_approaches_">Drug provocation tests: up-date and novel approaches.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013; 9(1):12.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23551800/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/12">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract"><h3>SUMMARY:</h3> Drug provocation tests (DPTs) are often needed when evaluating patients with suspected drug hypersensitivity reactions. General considerations on DPTs, with regard to indications, contraindications, methods, limitations and interpretations have been thoroughly addressed and various protocols are published. However, the field of drug allergy is changing and DPTs make no exception. Novel (or sometimes, simply renewed) approaches arise, awaiting to be either validated or refuted in larger studies in the future. Instead of covering the whole topic of DPTs, this paper will address these recent and challenging aspects.</div></div></div></description></item><item><title>Improper inhaler technique is associated with poor asthma control and frequent emergency department visits.</title><link>http://www.unboundmedicine.com/medline/citation/23510684/Improper_inhaler_technique_is_associated_with_poor_asthma_control_and_frequent_emergency_department_visits_</link><description><div class="result"><ul><li class="author">Al-Jahdali H, Ahmed A, Al-Harbi A, et al. </li><li class="title"><a href="./citation/23510684/Improper_inhaler_technique_is_associated_with_poor_asthma_control_and_frequent_emergency_department_visits_">Improper inhaler technique is associated with poor asthma control and frequent emergency department visits.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013; 9(1):8.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23510684/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/8">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Uncontrolled asthma remains a frequent cause of emergency department (ED) visits and hospital admissions. Improper asthma inhaler device use is most likely one of the major causes associated with uncontrolled asthma and frequent ED visits.To evaluate the inhaler technique among asthmatic patients seen in ED, and to investigate the characteristics of these patients and factors associated with improper use of inhaler devices and its relationship with asthma control and ED visits.A cross-sectional study of all the patients who visited the ED with bronchial asthma attacks over a 9-month period was undertaken at two major academic hospitals in Saudi Arabia. Information was collected about demographic data and asthma management and we assessed the inhaler techniques for each patient using an inhaler technique checklist.A total of 450 asthma patients were included in the study. Of these, 176(39.1%) were males with a mean age of 42.3 ±16.7 years and the mean duration of asthma was 155.9 ± 127.1 weeks. The improper use of asthma inhaler devices was observed in 203(45%) of the patients and was associated with irregular clinic follow-ups (p = 0.0001), lack of asthma education (p = 0.0009), uncontrolled asthma ACT (score ≤ 15) (p = 0.001), three or more ED visits (p = 0.0497), and duration of asthma of less than 52 weeks (p = 0.005). Multiple logistic regression analysis revealed that a lack of education about asthma disease (OR =1.65; 95% CI: 1.07, 2.54) or a lack of regular follow-up (OR =1.73; 95% CI: 1.08, 2.76) was more likely to lead to the improper use of an asthma inhaler device.Improper asthma inhaler device use is associated with poor asthma control and more frequent ED visits. We also identified many avoidable risk factors leading to the improper use of inhaler devices among asthma patients visiting the ED.</div></div></div></description></item><item><title>Proposed new mechanism for food and exercise induced anaphylaxis based on case studies.</title><link>http://www.unboundmedicine.com/medline/citation/23509907/Proposed_new_mechanism_for_food_and_exercise_induced_anaphylaxis_based_on_case_studies_</link><description><div class="result"><ul><li class="author">Chen JY, Quirt J, Lee KJ </li><li class="title"><a href="./citation/23509907/Proposed_new_mechanism_for_food_and_exercise_induced_anaphylaxis_based_on_case_studies_">Proposed new mechanism for food and exercise induced anaphylaxis based on case studies.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013; 9(1):11.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/11">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">We present two cases of food and exercise-induced anaphylaxis (FEIA) in patients with a diagnosis of oral allergy syndrome (OAS) to the implicated foods. Patient A had FEIA attributed to fresh coriander and tomato and Patient B to fresh celery. These food allergens have been implicated in OAS and have structural antigenic similarity to that of birch and/or grass. Both patients' allergies were confirmed by fresh skin prick tests. In both cases, strenuous exercise was antecedent to the systemic anaphylaxis reaction and subsequent ingestion without exercise produced only local symptoms of perioral pruritus. We review the current proposed mechanisms for food and exercise induced anaphylaxis to oral allergens and propose a novel and more biologically plausible mechanism. We hypothesize that the inhibitory effects of exercise on gastric acid secretion decreases the digestion of oral allergens and preserves structural integrity, thereby allowing continued systemic absorption of the allergen whether it be profilins, lipid transfer proteins, or other antigenic determinants.</div></div></div></description></item><item><title>Newly diagnosed chronic granulomatous disease in a 44 year old male presenting with recurrent groin cellulitis and colitis.</title><link>http://www.unboundmedicine.com/medline/citation/23497019/Newly_diagnosed_chronic_granulomatous_disease_in_a_44_year_old_male_presenting_with_recurrent_groin_cellulitis_and_colitis_</link><description><div class="result"><ul><li class="author">Chung AG, Cyr MM, Ellis AK </li><li class="title"><a href="./citation/23497019/Newly_diagnosed_chronic_granulomatous_disease_in_a_44_year_old_male_presenting_with_recurrent_groin_cellulitis_and_colitis_">Newly diagnosed chronic granulomatous disease in a 44 year old male presenting with recurrent groin cellulitis and colitis.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology">Allergy Asthma Clin Immunol 2013; 9(1):9.</li><li class="links"><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23497019/">PMC Free Full Text</span><span class="fulltext" data-link="http://www.aacijournal.com/content/9/1/9">Publisher Full Text</span></li></ul></div></description></item></channel></rss>